Vaxcyte, Inc. (PCVX)
USD 32.17
(5.27%)
USD 32.17
(5.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -368.22 Million USD | 54.91% |
| 2022 | -816.71 Million USD | -1464.53% |
| 2021 | -52.2 Million USD | 86.48% |
| 2020 | -386.2 Million USD | -556.64% |
| 2019 | -58.81 Million USD | 10.39% |
| 2018 | -65.63 Million USD | -105.61% |
| 2017 | -31.92 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -493.08 Million USD | 15.58% |
| 2024 Q3 | -1.02 Billion USD | -107.31% |
| 2024 Q1 | -584.09 Million USD | -58.62% |
| 2023 Q2 | -515.82 Million USD | 44.73% |
| 2023 FY | -368.22 Million USD | 54.91% |
| 2023 Q4 | -368.22 Million USD | 30.7% |
| 2023 Q3 | -531.32 Million USD | -3.0% |
| 2023 Q1 | -933.26 Million USD | -14.27% |
| 2022 Q3 | -346.42 Million USD | -59.66% |
| 2022 Q4 | -816.71 Million USD | -135.76% |
| 2022 Q2 | -216.96 Million USD | -20.99% |
| 2022 Q1 | -179.33 Million USD | -243.53% |
| 2022 FY | -816.71 Million USD | -1464.53% |
| 2021 Q3 | -110.87 Million USD | 26.11% |
| 2021 Q1 | -197.81 Million USD | 48.78% |
| 2021 FY | -52.2 Million USD | 86.48% |
| 2021 Q4 | -52.2 Million USD | 52.92% |
| 2021 Q2 | -150.06 Million USD | 24.14% |
| 2020 Q3 | -397.04 Million USD | 3.17% |
| 2020 Q1 | -154.79 Million USD | -163.18% |
| 2020 FY | -386.2 Million USD | -556.64% |
| 2020 Q4 | -386.2 Million USD | 2.73% |
| 2020 Q2 | -410.04 Million USD | -164.9% |
| 2019 Q1 | 66.09 Million USD | 0.0% |
| 2019 FY | -58.81 Million USD | 10.39% |
| 2019 Q4 | -58.81 Million USD | 0.0% |
| 2018 FY | -65.63 Million USD | -105.61% |
| 2017 FY | -31.92 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -558.253% |
| Alkermes plc | -166.73 Million USD | -120.84% |
| Agenus Inc. | 274.13 Million USD | 234.323% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 119.692% |
| Aptorum Group Limited | 1.35 Million USD | 27234.452% |
| Ardelyx, Inc. | 34.51 Million USD | 1166.954% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 8703.435% |
| Bicycle Therapeutics plc | -481.46 Million USD | 23.52% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1118.242% |
| ChromaDex Corporation | -24.04 Million USD | -1431.217% |
| Chimerix, Inc. | -25.51 Million USD | -1343.065% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 5384.486% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1455.21% |
| CRISPR Therapeutics AG | -150.84 Million USD | -144.11% |
| Precision BioSciences, Inc. | -85.41 Million USD | -331.129% |
| Dyadic International, Inc. | -6.37 Million USD | -5673.303% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2211.096% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4904.005% |
| Lantern Pharma Inc. | -21.7 Million USD | -1596.642% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -233.126% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -4210.189% |
| Incyte Corporation | -3.17 Billion USD | 88.403% |
| IO Biotech, Inc. | -140.69 Million USD | -161.713% |
| Jaguar Health, Inc. | 29.39 Million USD | 1352.856% |
| Novavax, Inc. | -298.29 Million USD | -23.444% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 6999.513% |
| Opthea Limited | 28.15 Million USD | 1407.743% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -2093.263% |
| ContextLogic Inc. | -232 Million USD | -58.719% |
| MiMedx Group, Inc. | -33.9 Million USD | -986.183% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3711.839% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -15792.219% |
| NextCure, Inc. | -6.47 Million USD | -5585.147% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -629.148% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -5672.488% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 3127.369% |
| PDS Biotechnology Corporation | -32.7 Million USD | -1025.77% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2231.19% |
| Pharming Group N.V. | 109.8 Million USD | 435.349% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -2016.734% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -110.139% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1888.282% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1888.282% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -5086.296% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -6183.737% |
| Acelyrin, Inc. | -216.9 Million USD | -69.766% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -6463.449% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -21258.875% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1161.969% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -5312.715% |
| Senti Biosciences, Inc. | 1.74 Million USD | 21262.471% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -99.465% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -375.432% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5974.348% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 369179.574% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 58734.873% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -214.6% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -118.879% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 432.125% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4747.643% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -185.195% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 5440.804% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -51.932% |
| Immix Biopharma, Inc. | -17.5 Million USD | -2002.978% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -16.269% |
| MEI Pharma, Inc. | -3.7 Million USD | -9838.65% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 3043.226% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 327.663% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1424.891% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4904.005% |
| Precigen, Inc. | -481 Thousand USD | -76454.47% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2715.063% |
| AlloVir, Inc. | -62.69 Million USD | -487.359% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -562.112% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 697.131% |
| ImmuCell Corporation | 10.99 Million USD | 3450.393% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -138.882% |
| Onconetix, Inc. | 5.33 Million USD | 7006.712% |
| PureTech Health plc | -167.19 Million USD | -120.235% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1108.887% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1826.075% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -7401.059% |
| Seer, Inc. | -4.24 Million USD | -8584.599% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1431.917% |
| Innoviva, Inc. | 255.56 Million USD | 244.085% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -559.149% |
| ESSA Pharma Inc. | -33.62 Million USD | -995.21% |
| GlycoMimetics, Inc. | -40.98 Million USD | -798.456% |
| GT Biopharma, Inc. | -1.02 Million USD | -35965.328% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -443.244% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 701.118% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -174.634% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2557.527% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1175.378% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -488692.577% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1093.14% |
| Aptose Biosciences Inc. | -8.19 Million USD | -4393.391% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -11668.133% |
| Soligenix, Inc. | -4.95 Million USD | -7336.53% |
| Century Therapeutics, Inc. | 847 Thousand USD | 43574.262% |
| Kura Oncology, Inc. | -20.11 Million USD | -1730.336% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -799.739% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -4284.699% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 20313.428% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -11417.892% |
| Autolus Therapeutics plc | -186.59 Million USD | -97.336% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -646.85% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -33.515% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1174.551% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 324.026% |
| GRI Bio, Inc. | -1.79 Million USD | -20425.474% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3999.133% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -1007.217% |
| IGM Biosciences, Inc. | -72.6 Million USD | -407.158% |
| INmune Bio, Inc. | -25.41 Million USD | -1349.085% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 343.938% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -626.874% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2166.1% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -12663.828% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1068.636% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -794.08% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1254.86% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 197.427% |
| Verastem, Inc. | -37.27 Million USD | -887.786% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3958.492% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -610.013% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -2332.95% |
| Histogen Inc. | -7.48 Million USD | -4818.218% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1604.217% |
| Surrozen, Inc. | -32.66 Million USD | -1027.318% |
| Organovo Holdings, Inc. | -1.5 Million USD | -24334.439% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8660.035% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 2042.104% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 14175.956% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 8960.13% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -4293.514% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -747.629% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2426.106% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -16.237% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -50896.732% |
| Apollomics, Inc. | -27.39 Million USD | -1244.139% |
| Amarin Corporation plc | -191.04 Million USD | -92.749% |
| Mesoblast Limited | 55.96 Million USD | 757.983% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2424.87% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1355.903% |
| Synaptogenix, Inc. | -28.66 Million USD | -1184.744% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -39240.491% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 855.616% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -42613.339% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4967.753% |
| Exelixis, Inc. | -73.05 Million USD | -404.075% |
| Better Therapeutics, Inc. | -860 Thousand USD | -42717.093% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1433.449% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -52.556% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 50126.356% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4850.529% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 29464.195% |
| Gritstone bio, Inc. | 39.49 Million USD | 1032.456% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -337.839% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -13889.643% |
| Avid Bioservices, Inc. | 169.72 Million USD | 316.951% |
| Insmed Incorporated | 721.62 Million USD | 151.028% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3928.075% |
| MediWound Ltd. | -5.32 Million USD | -6818.959% |
| OmniAb, Inc. | 9.2 Million USD | 4101.163% |
| Alector, Inc. | -35.63 Million USD | -933.272% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 528.315% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -7372.139% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2881.381% |
| Zai Lab Limited | -775 Million USD | 52.487% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 208.126% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1610.695% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -346.444% |
| Immunic, Inc. | -45.34 Million USD | -712.146% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -90.579% |
| Veracyte, Inc. | -203.82 Million USD | -80.659% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 157.689% |
| FibroGen, Inc. | 56.76 Million USD | 748.664% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4235.059% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -12924.985% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -17685.754% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 108.022% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -10921.461% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -121.872% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2161.51% |
| Galecto, Inc. | -21.21 Million USD | -1635.61% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1448.148% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 123.463% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1404.687% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -3100.026% |
| XBiotech Inc. | -200.02 Million USD | -84.092% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -337.839% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 8232.222% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -944.23% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -376.867% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 6570.339% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -116.077% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -298.626% |
| Vaxxinity, Inc. | 10.13 Million USD | 3734.297% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 150.013% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -3319.784% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -458.292% |
| NexImmune, Inc. | -3.13 Million USD | -11650.764% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -10564.983% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -2336.742% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1258.771% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -4002.326% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -295486.594% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -807.589% |
| Ainos, Inc. | 4.07 Million USD | 9129.757% |
| Pluri Inc. | 22.82 Million USD | 1712.979% |
| Prothena Corporation plc | -608.34 Million USD | 39.471% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -210.07% |
| Celularity Inc. | 65.19 Million USD | 664.852% |
| Rallybio Corporation | -24.1 Million USD | -1427.786% |
| Cue Biopharma, Inc. | -33.81 Million USD | -988.817% |
| MeiraGTx Holdings plc | -40.3 Million USD | -813.669% |
| Omeros Corporation | 331.17 Million USD | 211.188% |
| Humacyte, Inc. | -22.48 Million USD | -1537.583% |
| Immunocore Holdings plc | -358.59 Million USD | -2.686% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1398.38% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1091.635% |
| Blueprint Medicines Corporation | 702.83 Million USD | 152.392% |
| CalciMedica, Inc. | -5.53 Million USD | -6558.716% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -95.636% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3505.12% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -819.717% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -1007.35% |
| Pulmatrix, Inc. | -10.41 Million USD | -3434.866% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -6060.733% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -865.411% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -230.539% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -514.285% |
| Cytokinetics, Incorporated | 642.37 Million USD | 157.323% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -6223.665% |
| Nutriband Inc. | -251.65 Thousand USD | -146220.985% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -979.243% |
| Vor Biopharma Inc. | 4.3 Million USD | 8663.419% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 93.899% |
| Evogene Ltd. | -19.63 Million USD | -1775.456% |
| ProKidney Corp. | -56.23 Million USD | -554.789% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -656.548% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3886.354% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 126.998% |
| CorMedix Inc. | -43.05 Million USD | -755.298% |
| BioLineRx Ltd. | 7.33 Million USD | 5119.452% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1240.714% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 897.944% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1189.401% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 16608.505% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1513.898% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2176.273% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -390.485% |
| MediciNova, Inc. | -50.78 Million USD | -625.092% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -367.263% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1636828.206% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5606.655% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -84.278% |
| Biomea Fusion, Inc. | -166.57 Million USD | -121.064% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -105.742% |
| Mereo BioPharma Group plc | -51.46 Million USD | -615.435% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -288.245% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -25.35% |
| Absci Corporation | -72.59 Million USD | -407.214% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 8164.542% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -57.069% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -290.854% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -284.788% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -842.408% |
| Allakos Inc. | -24.97 Million USD | -1374.382% |
| Imunon, Inc. | -4.21 Million USD | -8638.489% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2397.809% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -171.955% |
| BioAtla, Inc. | -109.01 Million USD | -237.789% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 50126.356% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -39114.803% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 3177.277% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1636.674% |
| XOMA Corporation | -29 Million USD | -1169.748% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2123.593% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3984.15% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4843.308% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -195.442% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -76.893% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -350.271% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -296.955% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -42757.758% |
| Akari Therapeutics, Plc | -3.84 Million USD | -9476.775% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22789.585% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 126.666% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30892.017% |
| UroGen Pharma Ltd. | 4.39 Million USD | 8485.949% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 424.483% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 511796.451% |
| Orgenesis Inc. | 21.78 Million USD | 1790.355% |
| Entera Bio Ltd. | -10.62 Million USD | -3364.362% |
| GH Research PLC | -78.07 Million USD | -371.62% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1552.131% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1281.248% |
| Xencor, Inc. | 29.64 Million USD | 1342.164% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -18593.51% |
| Replimune Group, Inc. | 1.41 Million USD | 26178.399% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -150253.194% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -191.28% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30892.017% |
| Portage Biotech Inc. | -4.98 Million USD | -7292.632% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1636828.206% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -456.89% |
| OncoCyte Corporation | -6.56 Million USD | -5510.651% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 41132.055% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -7982.877% |
| Purple Biotech Ltd. | -14.13 Million USD | -2504.52% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1450.038% |
| scPharmaceuticals Inc. | -6.54 Million USD | -5526.081% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -2105.987% |
| HilleVax, Inc. | -165.48 Million USD | -122.514% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -14408.55% |
| Tharimmune, Inc. | -10.93 Million USD | -3267.308% |
| Genprex, Inc. | -6.73 Million USD | -5365.231% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 0.157% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -316.264% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -26183.155% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -11001.387% |
| OKYO Pharma Limited | -826.84 Thousand USD | -44433.82% |
| Savara Inc. | 153 Thousand USD | 240771.242% |
| Curis, Inc. | -23.88 Million USD | -1441.537% |
| Daré Bioscience, Inc. | -5.15 Million USD | -7039.072% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -47351.199% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5831.492% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 31174.008% |
| BeiGene, Ltd. | -2.25 Billion USD | 83.657% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 3084.374% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 39.457% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -98.413% |
| Erasca, Inc. | -37.21 Million USD | -889.432% |
| bluebird bio, Inc. | 108.57 Million USD | 439.158% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -28491.428% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 197.222% |
| DBV Technologies S.A. | -126.98 Million USD | -189.974% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -28491.428% |
| Moderna, Inc. | -2.9 Billion USD | 87.333% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -3457.061% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -3288.176% |
| Molecular Templates, Inc. | 707 Thousand USD | 52183.027% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1073.782% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 206.237% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -348.718% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -301.425% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1041.011% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -971.175% |
| MacroGenics, Inc. | -66.98 Million USD | -449.716% |
| RenovoRx, Inc. | -1.17 Million USD | -31291.901% |
| Adicet Bio, Inc. | -138.78 Million USD | -165.318% |
| Prime Medicine, Inc. | -27.94 Million USD | -1217.873% |
| Aditxt, Inc. | 18.12 Million USD | 2132.059% |
| Adagene Inc. | -87.62 Million USD | -320.219% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8740.076% |
| Quantum-Si incorporated | -118.55 Million USD | -210.591% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1122.711% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4826.649% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -659.09% |
| SciSparc Ltd. | -2.06 Million USD | -17731.816% |
| Vericel Corporation | 1.27 Million USD | 28935.317% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2970.682% |
| Minerva Neurosciences, Inc. | 41 Million USD | 998.022% |
| Generation Bio Co. | 31.44 Million USD | 1270.908% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -109.979% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1090.787% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 415.823% |
| Invivyd, Inc. | -198.47 Million USD | -85.527% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -307.917% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -15257.584% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -420.168% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -5295.267% |
| 2seventy bio, Inc. | 181.71 Million USD | 302.64% |
| ADMA Biologics, Inc. | 90.06 Million USD | 508.841% |
| Clene Inc. | 3.34 Million USD | 11124.76% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3954.157% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1611.808% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5606.655% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -7.004% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1316.275% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 307.258% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -8899.657% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 7461.595% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -6969.054% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -182.591% |
| Evaxion Biotech A/S | 5.28 Million USD | 7064.968% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -227.115% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -180.505% |
| Trevena, Inc. | 2.25 Million USD | 16407.662% |
| Surrozen, Inc. | -32.66 Million USD | -1027.318% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -614.865% |
| Cingulate Inc. | 3.08 Million USD | 12045.017% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -12437.521% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 5223.515% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3863.169% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -364.212% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -180.123% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -248.891% |
| Clearmind Medicine Inc. | -3.94 Million USD | -9239.612% |
| Kronos Bio, Inc. | -36.05 Million USD | -921.321% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 4013.561% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 25353.424% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -578.684% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2654.222% |
| ImmunityBio, Inc. | 618.22 Million USD | 159.562% |
| Korro Bio, Inc. | -132.94 Million USD | -176.981% |
| Kineta, Inc. | -4.54 Million USD | -8008.941% |
| BioVie Inc. | -17.73 Million USD | -1976.583% |
| Codexis, Inc. | -43.27 Million USD | -750.979% |
| Celularity Inc. | 65.19 Million USD | 664.852% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -11519.659% |
| Celcuity Inc. | 6.78 Million USD | 5528.267% |
| Virax Biolabs Group Limited | -3.36 Million USD | -10843.035% |
| Cibus, Inc. | -8.07 Million USD | -4458.393% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -8607.188% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 8157.484% |
| IN8bio, Inc. | -16.38 Million USD | -2146.794% |
| Kodiak Sciences Inc. | -103.87 Million USD | -254.49% |
| Annexon, Inc. | -193.75 Million USD | -90.048% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 1022952.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -2004.275% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -10381.839% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 134.927% |
| Eyenovia, Inc. | 1.25 Million USD | 29354.502% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1468.619% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -11254.517% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -1007.55% |
| Arcellx, Inc. | -296.95 Million USD | -24.0% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1787.763% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -525.439% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1676.557% |
| Moolec Science SA | 117.61 Thousand USD | 313175.602% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -858.949% |
| Geron Corporation | 14.76 Million USD | 2594.594% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -871.114% |
| Royalty Pharma plc | 5.65 Billion USD | 106.508% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -160.376% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -5168.345% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -6766.244% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -161.653% |
| Humacyte, Inc. | -22.48 Million USD | -1537.583% |
| Structure Therapeutics Inc. | -124.33 Million USD | -196.148% |
| 89bio, Inc. | -289.05 Million USD | -27.391% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1358.787% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -20552.103% |
| Genelux Corporation | -6.89 Million USD | -5237.397% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1085.573% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 540.468% |
| Notable Labs, Ltd. | -9.77 Million USD | -3666.643% |
| Liquidia Corporation | -80.17 Million USD | -359.273% |
| Mustang Bio, Inc. | -3.73 Million USD | -9756.183% |
| Immunovant, Inc. | -635.22 Million USD | 42.032% |
| Quantum-Si incorporated | -118.55 Million USD | -210.591% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1996.487% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -8787.931% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4687.355% |
| Acasti Pharma Inc. | -23 Million USD | -1500.639% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -10835.609% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2166.1% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -167.335% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -11715.925% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1556.293% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1883.02% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -117.528% |
| PepGen Inc. | -60.67 Million USD | -506.934% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1502.659% |
| United Therapeutics Corporation | -507.7 Million USD | 27.472% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1825.269% |
| Solid Biosciences Inc. | -47.75 Million USD | -671.156% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -42613.339% |
| Immuneering Corporation | -54.94 Million USD | -570.2% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8660.035% |
| Silo Pharma, Inc. | -3.52 Million USD | -10348.207% |
| Belite Bio, Inc | -87.27 Million USD | -321.935% |
| XOMA Corporation | -29 Million USD | -1169.748% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -420.852% |
| Bionomics Limited | 227 Million USD | 262.207% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -216.667% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14437.189% |
| uniQure N.V. | -102.95 Million USD | -257.672% |
| Cassava Sciences, Inc. | -121.13 Million USD | -203.978% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8740.076% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 999.189% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2978.564% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -11800.556% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 347483.962% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -11254.517% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4235.059% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4865.305% |
| Altimmune, Inc. | -134.48 Million USD | -173.801% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 285.912% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14437.189% |
| Compugen Ltd. | -12.9 Million USD | -2753.588% |
| Peak Bio, Inc. | 10.34 Million USD | 3661.135% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -130015.548% |
| Benitec Biopharma Inc. | -50.58 Million USD | -627.98% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -252.917% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1974.406% |
| Zura Bio Limited | -99.8 Million USD | -268.943% |
| PolyPid Ltd. | 6.17 Million USD | 6068.023% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 596.798% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1974.406% |
| Instil Bio, Inc. | 75.35 Million USD | 588.637% |
| argenx SE | -2.02 Billion USD | 81.85% |
| Immunome, Inc. | -97.02 Million USD | -279.502% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1536.928% |
| Verona Pharma plc | -220.44 Million USD | -67.04% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -413.258% |
| Shattuck Labs, Inc. | -121.42 Million USD | -203.257% |
| CervoMed Inc. | -7.79 Million USD | -4625.193% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -98.506% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -8320.466% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -179.51% |
| Moolec Science SA | 117.61 Thousand USD | 313175.602% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -15993.999% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2416.129% |
| AnaptysBio, Inc. | -18.15 Million USD | -1928.687% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1928.799% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -423.191% |
| NeurAxis, Inc. | 145.7 Thousand USD | 252829.581% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 3378.374% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1192.342% |
| Achilles Therapeutics plc | -126.92 Million USD | -190.116% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -413.258% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -56055.277% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1672.553% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 25353.424% |
| Nutriband Inc. | -251.65 Thousand USD | -146220.985% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2695.741% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4849.288% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 208.239% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1651.409% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 17.709% |
| Palisade Bio, Inc. | -12.06 Million USD | -2952.533% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -162.436% |
| Beam Therapeutics Inc. | -262.72 Million USD | -40.158% |
| Neurogene Inc. | -131.95 Million USD | -179.055% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1787.876% |
| AEON Biopharma, Inc. | -4.88 Million USD | -7445.635% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 2.377% |
| Sesen Bio, Inc. | -112.55 Million USD | -227.159% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -268.743% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -15583.964% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -843.543% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -342.145% |
| Athira Pharma, Inc. | -88.99 Million USD | -313.743% |
| Vaccinex, Inc. | -1.28 Million USD | -28489.053% |
| HCW Biologics Inc. | 2.85 Million USD | 12990.051% |
| XOMA Corporation | -29 Million USD | -1169.748% |
| Nektar Therapeutics | 210.24 Million USD | 275.146% |
| Arvinas, Inc. | -313.8 Million USD | -17.344% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22789.585% |
| Merus N.V. | -192.88 Million USD | -90.906% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 713.865% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -5207.394% |
| Rezolute, Inc. | -68.16 Million USD | -440.176% |
| Clene Inc. | 3.34 Million USD | 11124.76% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2692.349% |
| BeyondSpring Inc. | -13.75 Million USD | -2577.041% |
| Synlogic, Inc. | -6.68 Million USD | -5408.257% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 32571.517% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -4255.139% |
| Peak Bio, Inc. | 10.34 Million USD | 3661.135% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -346.769% |
| Krystal Biotech, Inc. | -350.23 Million USD | -5.137% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 396.658% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -117.891% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -11563.294% |
| MannKind Corporation | 143.89 Million USD | 355.893% |
| Ikena Oncology, Inc. | -109.15 Million USD | -237.34% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4763.651% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -1012.468% |
| Gossamer Bio, Inc. | 180.35 Million USD | 304.168% |
| CohBar, Inc. | -5.93 Million USD | -6108.796% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1137.821% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 8164.542% |
| Legend Biotech Corporation | -949.39 Million USD | 61.215% |
| Mural Oncology plc | -255.84 Million USD | -43.927% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1243.03% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -7716.918% |
| Disc Medicine, Inc. | -358.28 Million USD | -2.776% |
| Champions Oncology, Inc. | 4.81 Million USD | 7752.265% |
| REGENXBIO Inc. | 54.76 Million USD | 772.34% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -136834.702% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -143.82% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3985.96% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -356.387% |
| Vaxart, Inc. | -8.24 Million USD | -4368.232% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -633.813% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -189.565% |
| Cellectis S.A. | -43.85 Million USD | -739.647% |
| Longeveron Inc. | -2.9 Million USD | -12562.552% |
| Repare Therapeutics Inc. | -107.85 Million USD | -241.4% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 138.025% |
| Inozyme Pharma, Inc. | 12 Million USD | 3167.536% |
| Revolution Medicines, Inc. | -608.2 Million USD | 39.457% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -29837.154% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -38.892% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -145.367% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2253.339% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -49660.405% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.15% |
| Denali Therapeutics Inc. | -74.86 Million USD | -391.855% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2970.682% |
| Veru Inc. | 4.77 Million USD | 7803.544% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -3174.293% |
| Cingulate Inc. | 3.08 Million USD | 12045.017% |
| Passage Bio, Inc. | 4.58 Million USD | 8131.123% |
| Context Therapeutics Inc. | -14.44 Million USD | -2448.314% |
| Exicure, Inc. | 5.84 Million USD | 6395.555% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -59.837% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -830.571% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2446.74% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -526.013% |
| Nuvalent, Inc. | -335.38 Million USD | -9.792% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 21331.523% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -394.384% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -4042.036% |
| OmniAb, Inc. | 9.2 Million USD | 4101.163% |
| Anew Medical, Inc. | 1.43 Million USD | 25805.829% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2347.787% |
| Lipocine Inc. | -4.75 Million USD | -7644.66% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -235.276% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2517.615% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -626.874% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1579.299% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -5378.753% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -459.386% |
| Ocugen, Inc. | -32.52 Million USD | -1032.275% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -330.297% |
| Q32 Bio Inc. | -37.94 Million USD | -870.346% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -58534.873% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2621.761% |
| Equillium, Inc. | -22.39 Million USD | -1544.458% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1340.187% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -1028.604% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -148429.536% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 374.71% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 11614.29% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 112213.591% |
| Dominari Holdings Inc. | 195 Thousand USD | 188934.359% |
| Edesa Biotech, Inc. | -5.26 Million USD | -6891.329% |
| vTv Therapeutics Inc. | -8.91 Million USD | -4029.494% |
| Bio-Techne Corporation | 267.74 Million USD | 237.528% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2171.744% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -211.808% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -4282.09% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2810.655% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -50.224% |
| Nkarta, Inc. | 57.29 Million USD | 742.641% |
| BioCardia, Inc. | 212 Thousand USD | 173791.981% |
| Iterum Therapeutics plc | 13.43 Million USD | 2840.192% |